Glutamine Synthetase Variants Balancing CHO Selection and Productivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing glutamine synthetase variants used as selection markers in CHO cells often impair cell growth and bioprocess performance, making them unsuitable for manufacturing therapeutic antibodies, and there is a need for novel variants that balance selection stringency with cell culture performance.
Innovation Solution
Introduction of modified mammalian glutamine synthetase variants with mutations at specific amino acid positions (R298K, N10S, N10T, and N10Q) that do not interfere with substrate binding, providing increased selection stringency and stability, allowing for the development of highly productive and stable cell lines.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing glutamine synthetase variants are used as selection markers, then selection stringency is improved, but cell growth and bioprocess performance are impaired
Solution Approach 1:
The patent applies parameter changes by introducing specific amino acid substitutions (R298K, N10S, N10T, N10Q) at defined positions in the glutamine synthetase sequence. These parameter changes at the molecular level modify enzyme properties to achieve attenuated activity that provides selection stringency while preserving cell growth capability, thus resolving the contradiction between selection effectiveness and productivity
2Reliability
If glutamine synthetase variants with attenuated activity are introduced, then selection stringency is increased, but substrate binding is interfered with
Solution Approach 1:
The patent applies local quality by making targeted amino acid substitutions at specific positions (10 and 298) that are spatially distant from the substrate binding site. This localized modification approach changes enzyme properties where needed while preserving the integrity of the substrate binding region, thus achieving selection stringency without interfering with substrate binding
3Reliability
If selection pressure is increased to isolate productive cell lines, then selection stringency is improved, but cell culture performance deteriorates
Solution Approach 1:
The patent uses parameter changes by modifying the glutamine synthetase enzyme properties through specific amino acid substitutions. This creates an optimized selection marker with attenuated activity that provides sufficient selection pressure to isolate productive cell lines while maintaining cell culture performance, thus resolving the contradiction between selection stringency and ease of operation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The modified glutamine synthetase variants enhance selection stringency and stability, resulting in higher productivity and longer phenotypic stability of CHO cell lines, particularly in the absence of glutamine synthetase inhibitors like MSX.
Implementation Method 1
Glutamine synthetase (EC 6.3.1.2, also known as γ-glutamyl: ammonia ligase) catalyzes ATP-dependent condensation of ammonia and glutamate to form glutamine
Data Source
AI summary
The invention relates to a modified mammalian glutamine synthetase comprising a mutation at amino acid position 10 and/or 298 in a mammalian glutamine synthetase, wherein the mutation is selected from the group consisting of R298K, N10S, N10T and N10Q and to an expression vector, a nucleic acid and a eukaryotic host cell encoding said modified mammalian glutamine synthetase and to its use as a selection marker. The invention further relates to methods for preparing stable cell lines, or for producing a protein of interest using said modified mammalian glutamine synthetase for selection.